Washington, D.C. - The Prescription Drug User Fee Act of 1992 reducedthe time the U.S. Food and Drug Administration needs to review and approvenew pharmaceuticals, said the Tufts Center for the Study of Drug Development.
POLL: Are You Attending the American Academy of Dermatology Annual Meeting?
ReV Up Your Vitiligo Treatment Strategies
Addressing Cardiovascular Risk Factors in Psoriasis Patients
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
The Weekly Roundup: February 26-March 1
Pointers With Portela: Dangerous Skin Care Marketing
2 Commerce Drive Cranbury, NJ 08512